Is B-IBD expected to be a treatment that will have

Is B-IBD expected to be a treatment that will have to be taken for life to combat IBD conditions already in the body or, once the condition is cleared, does the underlying issue that caused the condition end so the patient can stop taking B-IBD?

Could there be a preventative treatment for infants to prevent IBD conditions from beginning? Would be nice to think it could work like the regular shots infants get early in life to prevent serious conditions from arising. Also would be nice for shareholders if it should become standard issue for all babies in the future.

I am not medically trained so this entire post postulates my WAGs regarding possible uses and delivery systems for Brilacidin.

From what I get regarding microtablets, IPIX could have a family of capsules for IBD issues (one for UC for early in the intestines, than one for Crohn's a little later in the intestines, and finally one for sigmoidcolitis for the end of the intestines and this one may be used in conjunction with a foam/get applied directly into the rectum). There could also be a capsule for B to target needs in areas of the body other than the intestines and needing quick absorption into the bloodstream. Thinking of maybe a two-sided treatment for skin conditions with a capsule being used in tandem with a topical cream. Don't know what delivery system would be used for problems of the throat down to the GI tract entering the stomach.

Brilacidin IMO is akin to a prospector being at the entrance to the Lost Dutchman Mine. Going to take time to get a grasp on the entire system but every shaft explored should produce gold in varying amounts. Seems impossible to believe that an astute BP doesn't see the possibilities of this drug in addition to the already proven results for OM, IBD, and ABSSSI and is about to step up to the plate and claim this potentially company-changing drug for themselves. Get 'er done!!